PLATINUM-CATALYZED INTRAVAGINAL RINGS
    1.
    发明申请
    PLATINUM-CATALYZED INTRAVAGINAL RINGS 有权
    铂催化内环

    公开(公告)号:US20140056961A1

    公开(公告)日:2014-02-27

    申请号:US14051544

    申请日:2013-10-11

    CPC classification number: A61K9/0036 A61K31/444 A61K31/505

    Abstract: The present invention provides improved intravaginal drug delivery devices, i.e., intravaginal rings, useful for the prophylactic administration of an antimicrobial compound, e.g., Dapivirine, to a human. The intravaginal rings of the invention address previous stability issues by utilizing a platinum catalyst (e.g., in the form of a platinum-siloxane complex) for the cross-linking reaction. The vaginal rings surprisingly achieve relatively high and steady release rates in vivo with a matrix ring containing a relatively small loading dose. While the matrix rings of the present invention have in vivo the steady release rates associated with reservoir rings, they are easier and less expensive to manufacture. The present invention also provides methods of blocking DNA polymerization by an HIV reverse transcriptase enzyme, methods of preventing HIV infection in a female human, methods of treating HIV infection in a female human, and methods of preparing platinum-catalyzed intravaginal rings.

    Abstract translation: 本发明提供改进的阴道内药物递送装置,即阴道内环,其可用于向人类预防性施用抗微生物化合物例如达匹维林。 本发明的阴道内环通过利用铂催化剂(例如铂 - 硅氧烷复合物的形式)来解决先前的稳定性问题,用于交联反应。 使用含有相对小的负荷剂量的基质环,阴道环令人惊讶地在体内达到相对高且稳定的释放速率。 尽管本发明的基质环体内具有与储库环相关联的稳定释放速率,但它们制造更容易且成本更低。 本发明还提供了通过HIV逆转录酶阻断DNA聚合的方法,在女性人体中预防HIV感染的方法,在女性人体中治疗HIV感染的方法,以及制备铂催化的阴道内环的方法。

    Platinum-catalyzed intravaginal rings
    3.
    发明授权
    Platinum-catalyzed intravaginal rings 有权
    铂催化的阴道内环

    公开(公告)号:US08580294B2

    公开(公告)日:2013-11-12

    申请号:US13276454

    申请日:2011-10-19

    CPC classification number: A61K9/0036 A61K31/444 A61K31/505

    Abstract: The present invention provides improved intravaginal drug delivery devices, i.e., intravaginal rings, useful for the prophylactic administration of an antimicrobial compound, e.g., Dapivirine, to a human. The intravaginal rings of the invention address previous stability issues by utilizing a platinum catalyst (e.g., in the form of a platinum-siloxane complex) for the cross-linking reaction. The vaginal rings surprisingly achieve relatively high and steady release rates in vivo with a matrix ring containing a relatively small loading dose. While the matrix rings of the present invention have in vivo the steady release rates associated with reservoir rings, they are easier and less expensive to manufacture. The present invention also provides methods of blocking DNA polymerization by an HIV reverse transcriptase enzyme, methods of preventing HIV infection in a female human, methods of treating HIV infection in a female human, and methods of preparing platinum-catalyzed intravaginal rings.

    Abstract translation: 本发明提供改进的阴道内药物递送装置,即阴道内环,其可用于向人类预防性施用抗微生物化合物例如达匹维林。 本发明的阴道内环通过利用铂催化剂(例如铂 - 硅氧烷复合物的形式)来解决先前的稳定性问题,用于交联反应。 使用含有相对小的负荷剂量的基质环,阴道环令人惊讶地在体内达到相对高且稳定的释放速率。 尽管本发明的基质环体内具有与储库环相关联的稳定释放速率,但它们制造更容易且成本更低。 本发明还提供了通过HIV逆转录酶阻断DNA聚合的方法,在女性人体中预防HIV感染的方法,在女性人体中治疗HIV感染的方法,以及制备铂催化的阴道内环的方法。

    PLATINUM-CATALYZED INTRAVAGINAL RINGS
    4.
    发明申请
    PLATINUM-CATALYZED INTRAVAGINAL RINGS 有权
    铂催化内环

    公开(公告)号:US20120093911A1

    公开(公告)日:2012-04-19

    申请号:US13276454

    申请日:2011-10-19

    CPC classification number: A61K9/0036 A61K31/444 A61K31/505

    Abstract: The present invention provides improved intravaginal drug delivery devices, i.e., intravaginal rings, useful for the prophylactic administration of an antimicrobial compound, e.g., Dapivirine, to a human. The intravaginal rings of the invention address previous stability issues by utilizing a platinum catalyst (e.g., in the form of a platinum-siloxane complex) for the cross-linking reaction. The vaginal rings surprisingly achieve relatively high and steady release rates in vivo with a matrix ring containing a relatively small loading dose. While the matrix rings of the present invention have in vivo the steady release rates associated with reservoir rings, they are easier and less expensive to manufacture. The present invention also provides methods of blocking DNA polymerization by an HIV reverse transcriptase enzyme, methods of preventing HIV infection in a female human, methods of treating HIV infection in a female human, and methods of preparing platinum-catalyzed intravaginal rings.

    Abstract translation: 本发明提供改进的阴道内药物递送装置,即阴道内环,其可用于向人类预防性施用抗微生物化合物例如达匹维林。 本发明的阴道内环通过利用铂催化剂(例如铂 - 硅氧烷复合物的形式)来解决先前的稳定性问题,用于交联反应。 使用含有相对小的负荷剂量的基质环,阴道环令人惊讶地在体内达到相对高且稳定的释放速率。 尽管本发明的基质环体内具有与储库环相关联的稳定释放速率,但它们制造更容易且成本更低。 本发明还提供了通过HIV逆转录酶阻断DNA聚合的方法,在女性人体中预防HIV感染的方法,在女性人体中治疗HIV感染的方法,以及制备铂催化的阴道内环的方法。

    Infection control bedding product
    9.
    发明授权
    Infection control bedding product 有权
    感染控制床上用品

    公开(公告)号:US08561233B2

    公开(公告)日:2013-10-22

    申请号:US12678124

    申请日:2008-09-15

    Abstract: A hermetically sealed infection control bedding product such as a pillow, duvet, mattress, cushion or such like having a sealed cover and having a resiliently deformable filling material, comprising a vent means in the cover, characterized in that the vent means comprises a filter medium including a filter membrane for the removal of particles of microbial size and wherein the filter medium also comprises a strengthening layer of material for providing mechanical strength to the filter medium whereby the filter medium allows air flow therethrough but is substantially impermeable to liquid while maintaining a barrier to particles of microbial size.

    Abstract translation: 一种气密密封的感染控制床上用品,例如具有密封盖并具有可弹性变形的填充材料的枕头,羽绒被,床垫,衬垫等,其包括在盖中的通气装置,其特征在于,排气装置包括过滤介质 包括用于去除微生物尺寸的微粒的过滤膜,并且其中过滤介质还包括用于向过滤介质提供机械强度的强化层,由此过滤介质允许空气流过其中,但是在保持屏障的同时基本上不透液体 到微生物大小的颗粒。

Patent Agency Ranking